Ongoing cybersecurity concerns in the medical device space has resulted in more discussions around the significance of what software bills of materials (SBOMs) can provide in support of the sector.

The medical device sector is under pressure to improve software supply chain security, and software bills of materials (SBOMs) are front and center. ReversingLabs talks with Professor Kevin Fu of the Archimedes Center at University of Michigan about what to expect.

Since it was released a year ago, the White House’s Executive Order on Improving the Nation’s Cybersecurity (EO 14028) has generated discussion about its impact on software development organizations, federal agencies —  and even enterprises, which now must embrace concepts like software bills of materials (SBOMs) if they sell to Uncle Sam.

But in the medical devices industry, discussions of supply chain security aren’t new. And, while other industries are still wrapping their head around concepts like SBOMs, officials at the Food and Drug Administration (FDA) and its peer agencies in other countries are moving quickly to embrace them as they face growing threats and attacks on vulnerable medical devices and clinical environments. 

Read the full article at Security Boulevard.